Literature DB >> 26202878

Prognostic value of extracardiac incidental findings on attenuation correction cardiac computed tomography.

Waqas T Qureshi1, Zaid Alirhayim2,3, Fatima Khalid1, Mouaz H Al-Mallah4,5,6.   

Abstract

BACKGROUND: Attenuation corrected computed tomography (CTAC) is often performed to improve the specificity of single-photon emission tomography imaging. Extracardiac incidental findings are frequently observed. It is unclear whether these findings have any prognostic value.
METHODS: Consecutive patients (n = 1139) at a tertiary care center were retrospectively evaluated for incidental findings on CTAC. Clinically significant incidental findings were defined as findings warranting physician follow-up. Information regarding subsequent resource utilization was obtained by chart review. Cox proportional hazard model adjusted for demographic and clinical variables was used to evaluate association of these incidental findings with all-cause and cancer-specific mortality.
RESULTS: A total of 135 (12%) patients with incidental findings were identified, 83 of whom (68%) were newly diagnosed. Lung nodules were the most common finding, present in 92 (68%) patients. Over a median follow-up of 468 days, incidental findings were not significantly associated with increased risk of all-cause mortality (HR 1.34; 95% CI 0.77-2.33, P = 0.29) but was significantly associated with cancer-specific mortality (HR 3.21; 95% CI 1.26-8.14, P = 0.01). This association remained statistically significant when the analysis was limited to newly diagnosed incidental findings. Among patients with incidental findings, follow-up radiographic studies were conducted in 87%, and invasive procedures performed in 32%. Physician office-based follow-up of these findings occurred in 42% of patients and incidental finding-related hospitalization occurred in 14%.
CONCLUSIONS: This study shows that incidental findings are common and were associated with all-cause and cancer-specific mortality but only the later remained statistically significant after multivariable adjustment.

Entities:  

Keywords:  Incidental findings; attenuation corrected computed tomography; cardiac imaging; mortality

Mesh:

Year:  2015        PMID: 26202878     DOI: 10.1007/s12350-015-0223-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  23 in total

1.  American Society of Nuclear Cardiology and Society of Nuclear Medicine joint position statement: attenuation correction of myocardial perfusion SPECT scintigraphy.

Authors:  Gary V Heller; Jonathan Links; Timothy M Bateman; Jack A Ziffer; Edward Ficaro; Mylan C Cohen; Robert C Hendel
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

Review 2.  Hybrid imaging technology: from dreams and vision to clinical devices.

Authors:  James A Patton; David W Townsend; Brian F Hutton
Journal:  Semin Nucl Med       Date:  2009-07       Impact factor: 4.446

3.  Incidental findings of cardiac MSCT: who might benefit from scanning the entire thorax on Ca score imaging?

Authors:  Omer Yiginer; Serap Bas; Suheyl Pocan; Ahmet Yildiz; Sedat Alibek
Journal:  Int J Cardiol       Date:  2008-12-14       Impact factor: 4.164

4.  Incidental findings on cardiac computed tomography. Should we look?

Authors:  Matthew J Budoff; Ambarish Gopal
Journal:  J Cardiovasc Comput Tomogr       Date:  2007-05-18

5.  Ethical issues related to lung nodules on cardiac CT.

Authors:  Matthew Jay Budoff
Journal:  AJR Am J Roentgenol       Date:  2009-03       Impact factor: 3.959

6.  Attenuation-corrected thallium-201 single-photon emission tomography using a gadolinium-153 moving line source: clinical value and the impact of attenuation correction on the extent and severity of perfusion abnormalities.

Authors:  H J Gallowitsch; J Sykora; P Mikosch; E Kresnik; O Unterweger; M Molnar; G Grimm; P Lind
Journal:  Eur J Nucl Med       Date:  1998-03

7.  Prevalence of noncardiac findings on low dose 64-slice computed tomography used for attenuation correction in myocardial perfusion imaging with SPECT.

Authors:  Lars Husmann; Fuminari Tatsugami; Ursina Aepli; Bernhard A Herzog; Ines Valenta; Patrick Veit-Haibach; Ronny R Buechel; Aju P Pazhenkottil; Oliver Gaemperli; Nina Burkhard; Christophe A Wyss; Philipp A Kaufmann
Journal:  Int J Cardiovasc Imaging       Date:  2009-08-07       Impact factor: 2.357

8.  Potential clinical and economic consequences of noncardiac incidental findings on cardiac computed tomography.

Authors:  Jimmy Machaalany; Yeung Yam; Terrence D Ruddy; Arun Abraham; Li Chen; Rob S Beanlands; Benjamin J W Chow
Journal:  J Am Coll Cardiol       Date:  2009-10-13       Impact factor: 24.094

9.  Cost-effectiveness of follow-up of pulmonary nodules incidentally detected on cardiac computed tomographic angiography in patients with suspected coronary artery disease.

Authors:  Alexander Goehler; Pamela M McMahon; Heidi S Lumish; Carol C Wu; Vidit Munshi; Michael Gilmore; Jonathan H Chung; Brian B Ghoshhajra; Daniel Mark; Quynh A Truong; G Scott Gazelle; Udo Hoffmann
Journal:  Circulation       Date:  2014-07-11       Impact factor: 29.690

Review 10.  Review: comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imaging.

Authors:  Adam A Ghotbi; Andreas Kjaer; Philip Hasbak
Journal:  Clin Physiol Funct Imaging       Date:  2013-09-13       Impact factor: 2.273

View more
  12 in total

Review 1.  Review of cardiovascular imaging in the journal of nuclear cardiology in 2015. Part 1 of 2: Plaque imaging, positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

Review 2.  Review of Cardiovascular Imaging in the Journal of Nuclear Cardiology in 2016. Part 1 of 2: Positron Emission Tomography, Computed Tomography and Magnetic Resonance.

Authors:  Wael AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-02-13       Impact factor: 5.952

3.  The good, bad, and ugly of incidental findings on cardiovascular-computed tomography.

Authors:  Pradeep Bhambhvani
Journal:  J Nucl Cardiol       Date:  2015-07-24       Impact factor: 5.952

4.  Extracardiac findings on computed tomography attenuation correction: Is it worth paying extra attention?

Authors:  Dominik C Benz; Tobias A Fuchs
Journal:  J Nucl Cardiol       Date:  2017-05-08       Impact factor: 5.952

5.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2018. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2019-01-02       Impact factor: 5.952

6.  Incidental detection of abnormal 99mTc-sestamibi uptake in the sternum and ribcage from multiple myeloma by SPECT myocardial perfusion imaging.

Authors:  Ayman A Farag; Hiren Patel; Pradeep Bhambhvani; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2016-07-28       Impact factor: 5.952

7.  Incidental renal masses on SPECT/CT and PET/CT.

Authors:  Jorge D Oldan; Amir H Khandani
Journal:  Am J Nucl Med Mol Imaging       Date:  2022-06-15

Review 8.  2022 ASNC/AAPM/SCCT/SNMMI guideline for the use of CT in hybrid nuclear/CT cardiac imaging.

Authors:  Mouaz H Al-Mallah; Timothy M Bateman; Kelley R Branch; Andrew Crean; Eric L Gingold; Randall C Thompson; Sarah E McKenney; Edward J Miller; Venkatesh L Murthy; Koen Nieman; Todd C Villines; Michael V Yester; Andrew J Einstein; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2022-09-02       Impact factor: 3.872

Review 9.  Multimodality Imaging of Pericardial Diseases.

Authors:  Mouaz H Al-Mallah; Fatimah Almasoudi; Mohamed Ebid; Amjad M Ahmed; Abdelrahman Jamiel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-10-12

Review 10.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2020: positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2021-06-08       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.